Drug Target Insights (Jan 2007)

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives

  • Angelis Konstantinopoulos,
  • Konstantinos Giannitsas,
  • Spiros Raptis,
  • Petros Perimenis

Journal volume & issue
Vol. 2
pp. 111 – 117

Abstract

Read online

Endothelial dysfunction is a pathological entity that multiply affects the health status. Erectile dysfunction is being recognized as a condition that is strongly interrelated with endothelial dysfunction, being a vascular event itself. Oral pharmacotherapy for erectile dysfunction has provided us with a new armamentarium on this condition. Phosphodiesterase 5 inhibitors have been investigated and proved useful in clinical practice for erectile dysfunction but in addition to this, the results seem promising of a benefi cial effect on endothelial dysfunction, as well.

Keywords